Lirentelimab
Lirentelimab (AK002) is a humanized anti-sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) antibody that induces apoptosis of IL-5-activated eosinophils and inhibits IL-5-mediated mast cell activation, and is used in the study of refractory inert systemic mastocytosis and allergic conjunctivitis.
Product Specifications
CAS Number
2283348-97-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Apoptosis
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS850585-02 0.1 mL (AF635)
Carcinoembryonic Antigen (CEA) Antibody
Sign In for Pricing
View Details MBS850585-03 0.1 mL (AF610)
Carcinoembryonic Antigen (CEA) Antibody
Sign In for Pricing
View Details MBS850585-04 0.1 mL (AF405S)
Carcinoembryonic Antigen (CEA) Antibody
Sign In for Pricing
View Details MBS850585-05 0.1 mL (AF405L)
Carcinoembryonic Antigen (CEA) Antibody
Sign In for Pricing
View Details MBS850585-06 0.1 mL (AF546)
Carcinoembryonic Antigen (CEA) Antibody
Sign In for Pricing
View Details